Unfractionated Heparin Market
According to Intent Market Research, the Unfractionated Heparin Market is expected to grow from USD 8.5 billion in 2024-e at a CAGR of 4.5% to touch USD 11.5 billion by 2030. The Unfractionated Heparin Market is dominated by key players such as B. Braun Melsungen AG, Pfizer Inc., Sanofi, Fresenius Kabi and Leo Pharma.